Do not conflate melanocortin-related substances
FDA identifies safety concerns for Melanotan II. Evidence or approval associated with an afamelanotide or bremelanotide product is not evidence for this reference.
Documentation to request
Request exact chemical identity and the source of any claimed use. Assess the vial and spray separately, without inferring tanning safety.
Regulatory context: FDA: substance-specific safety concerns. Source reviewed . This source does not verify the identity, testing or availability of our catalog references.
Related guidance: Product-by-product review for hormone clinics. These references support a review, not a treatment recommendation or supply authorization.